Form 8-K - Current report:
SEC Accession No. 0000950135-06-004243
Filing Date
2006-07-10
Accepted
2006-07-10 17:01:44
Documents
1
Period of Report
2006-07-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 ALNYLAM PHARMACEUTICALS, INC. FORM 8-K b61529ape8vk.htm 8-K 13194
  Complete submission text file 0000950135-06-004243.txt   14781
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50743 | Film No.: 06954468
SIC: 2834 Pharmaceutical Preparations